Get in touch

Submit

Thank you

Jonathan will also lead the firm’s Cambridge office, where he has been based for several years now. Jonathan has been with Keltie since joining the patent profession and has become an integral part of the Life Sciences and Chemistry team. He has wide range of clients in the pharmaceuticals, cell therapy and agritech sectors and is looking to grow this practice further within the East of England.

Keltie partner, Devanand Crease, says “I have worked closely with Jonathan for over a decade. He has a great touch with clients and really goes the extra mile to seek out a commercial solution for them. This is what makes him a natural choice to lead the firm’s expansion in Cambridge and East of England.”

 

Jonathan said “It is an honour and privilege to be made partner at a firm where I started and learnt the profession. I am truly grateful to work with the same great people who have made this journey possible and who have supported me every step of the way. Keltie is a fantastic place to work where the values instilled in us all by our founder, David Keltie, remain strong. While my focus going forward will be in Cambridge and the East of England, we are one firm – and a great one at that!”

 

For 35 years, Keltie has sought to break the mould of traditional IP firms by creating an environment where talented individuals can enjoy building great relationships with exceptional clients. In that time, we have grown a diverse partnership across the patent and trademark practice. A partnership that continues to advance the inclusive ideals that founded the firm. Keltie attorneys work on the full spectrum of clients, from start-ups to multinational corporations. We value the relationships with our clients and work hard to build a level of understanding that allows us to anticipate challenges, as well as see opportunities. We are proud that Keltie attorneys are unique and it is our uniqueness that allows us to build outstanding IP relationships across the UK, Ireland, Europe and beyond.

Continue reading about Jonathan Goodacre promoted to Partner
MoreSetting your IP strategy - Part II: Monetisation of IP

18.06.2025

Setting your IP strategy - Part II: Monetisation of IP

Businesses may be deterred from taking steps to acquire IP rights because of the associated costs; however, when acquired strategically, IP rights can provide a substantial revenue stream. Following on from the first article in this series, the following considers how patents, trade secrets, and more may be monetised in practice, particularly in the field of AI.

MoreThe Effect of the Unified Patent Court (UPC) on Opposition Proceedings at the European Patent Office (EPO)

02.05.2025

The Effect of the Unified Patent Court (UPC) on Opposition Proceedings at the European Patent Office (EPO)

The introduction of the Unified Patent Court (UPC) has brought significant changes to the European patent landscape. This article, written by Nathaniel Taylor (of Keltie's Opposition and Appeals team), takes a closer look at the impact of the UPC on opposition proceedings at the European Patent Office (EPO). The article draws on a full year's worth of opposition data - available as of 1 April 2025 - for European patents granted since the Unitary Patent system began (i.e., European patents granted between 1 June 2023 and 1 June 2024). The analysis explores overall trends, technology-specific patterns, and the strategic motives behind relative opposition rates.

Get in touch

Submit

Thank you